Skip to main content

Table 4 CVD risk inicators at baseline, and changes during intervention

From: Effectiveness of a physical activity program on cardiovascular disease risk in adult primary health-care users: the “Pas-a-Pas” community intervention trial

  Baseline   Changes during intervention (End - Baseline)  
  CG (n = 104) IG (n = 260) p CG (n = 104) IG (n = 260) p
SBP (mmHg) 135.32 (16.62) 131.06 (15.94) 0.280 0.90 (18.63) −3.59 (16.45) 0.029
DBP (mmHg) 75.96 (9.86) 76.75 (9.09) 0.478 −1.29 (10.64) −3.03 (9.75) 0.140
Weight (Kg) 75.72 (14.92) 75.37 (14.80) 0.843 0.08 (4.52) −1.23 (8.02) 0.151
BMI (Kg/m2) 29.95 (4.88) 30.01 (5.02) 0.924 −0.03 (1.91) −0.22 (2.38) 0.471
WC (cm) 100.31 (11.74) 100.50 (11.81) 0.895 −1.58 (5.79) −2.96 (8.99) 0.168
Total Cholesterol (mg/dL) 206.83 (32.67) 205.26 (36.58) 0.713 0.09 (32.96) −10.68 (31.81) 0.006
HDL-cholesterol (mg/dL) 56.37 (16.09) 55.51 (14.86) 0.641 −1.18 (10.26) −0.07 (12.37) 0.435
LDL-cholesterol (mg/dL) 122.70 (29.62) 122.33 (34.14) 0.922 1.82 (26.48) −7.18 (29.04) 0.009
TG (mg/dL) 134.63 (83.91) 132.26 (67.75) 0.786 −3.11 (60.33) −3.26 (60.26) 0.983
HbA1c (%) 7.21 (1.61) 7.40 (1.37) 0.599 −0.33 (1.42) −0.08 (1.20) 0.476
Glucose (mg/dL) 99.19 (33.91) 98.66 (28.42) 0.883 −5.16 (21.04) 2.96 (19.45) 0.001
REGICOR 4.63 (3.54) 4.60 (3.97) 0.962 0.37 (2.53) −0.28 (2.55) 0.064
Change from smoking to non-smoking       
 Smoking (%) 4.20 7.90 0.123 1.00 0.90 0.369
  1. Values are expressed in mean and (standard deviation)
  2. CG Control group, IG Intervention group, SBP Systolic blood pressure, DBP Diastolic blood pressure, BMI Body mass index, WC Waist circumference, HDL High-density lipoprotein, LDL Low-density lipoprotein, TG Triglycerides, HbA1c Glycated hemoglobin; Cardiovascular disease risk REGICOR scale